NCT03128580 (AMOS) is a clinical trial in Euploid Embryos, sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA.

Who is sponsoring NCT03128580?

NCT03128580 is sponsored by Instituto Valenciano de Infertilidad, IVI VALENCIA.

What condition does NCT03128580 study?

NCT03128580 studies Euploid Embryos.

Is NCT03128580 still recruiting?

NCT03128580 is currently terminated. Last updated 23 July 2020.

Last reviewed 2020-07-23 · How we verify

NCT03128580: AMOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated IVF Cycles

Terminated Last updated 23 July 2020

What this trial tests

trial in Euploid Embryos in 40 participants. Terminated before completion.

Timeline

21 April 2017

Primary endpoint
7 April 2020

3 July 2020

Quick facts

Lead sponsor	Instituto Valenciano de Infertilidad, IVI VALENCIA
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	40
Start date	21 April 2017
Primary completion	7 April 2020
Estimated completion	3 July 2020
Sites	3 locations across Spain

Conditions studied

Euploid Embryos — all drugs for Euploid Embryos →

Sponsor

Instituto Valenciano de Infertilidad, IVI VALENCIA — full company profile →

Who can join

Adults 30 to 38, female only, with Euploid Embryos. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare the number of euploid embryos obtained per metaphase II oocyte in unstimulated (modified natural cycles) and stimulated IVF cycles.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Instituto Valenciano de Infertilidad, IVI VALENCIA trials

Trials by the same sponsor.

NCT06193135 — Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitar · NA · recruiting
NCT06384794 — Study of the ZyMōt Sperm Selection Method and Its Effect on Embryo Ploidy. · NA · recruiting
NCT06103383 — Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women · NA · unknown
NCT05440019 — Evaluation of the Safety and Usability of the M3T Fertigo System and Its Calibration · completed
NCT05161338 — Impact of Vaginal Microbiome on Vaginal Absorption of Exogenous Progesterone: a Pilot Study. · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03128580 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Instituto Valenciano de Infertilidad, IVI VALENCIA
Last refreshed: 23 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03128580.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing